CELL DEATH DIFFER 润色咨询

CELL DEATH AND DIFFERENTIATION

出版年份:1994 年文章数:2573 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2168454, encodeId=71b521684548f, content=10.25 under consideration,11.13 Decision Made <br>是不是凉了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Tue Nov 14 14:23:49 CST 2023, time=2023-11-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171915, encodeId=c00021e19157e, content=审稿速度:1.0<br>经验分享:投稿9天了,还没有分配编辑。正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Nov 29 19:12:44 CST 2023, time=2023-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174411, encodeId=00cd21e441127, content=12月3日投稿,12月12日分配编辑,状态从under consideration变成decision made,等的很心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231212/49c44b7487594cb2a1457534d314b6f1/47f94596e582468ca6223cd97aa1f914.jpg, createdBy=a7645496639, createdName=ms9000001631056614, createdTime=Tue Dec 12 10:00:50 CST 2023, time=2023-12-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2112903, encodeId=38b6211290323, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:分子生物学;细胞生物<br>经验分享:做的泛素化和肿瘤相关的,我发现大CDD特别喜欢泛素化领域的,可以说是非常对口了。2022年7月份投稿,审稿特别快我记得只用了20天左右,但21年也投过一次审了50多天,这个不好说感觉看运气。这次三个审稿人,总共提大概20个问题(在这之前也投过其他杂志修过稿,估计也提不出太多),给了4个月修稿。每个问题都按要求非常仔细的修改或补充实验,花了刚好3个月时间修回。二审用了17天,所有审稿人对修改稿非常满意,被告知原则性接收。接下来按编辑的要求修改格式提交终稿等等,但提交后等了好久没消息,可能是因为年底欧洲那边休假比较多吧(也可能和世界杯有关系。。),一个月后才正式接收。最后交版面费和校稿等又花了一个月正式online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230911/cbd6c125e27947f9b1410a5defdb543f/5001c9b5eb424717bd69704b333cad05.jpg, createdBy=11262341875, createdName=12291c48m73(暂无昵称), createdTime=Fri Feb 03 17:00:45 CST 2023, time=2023-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2188705, encodeId=5ed52188e0542, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:上皮间质转化<br>经验分享:在投,想问以下,在投稿系统选择转投小CDD,是在大CDD拒稿后会发链接让转投吗,还是直接就转了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13c25384818, createdName=大鱼659, createdTime=Thu Feb 22 15:55:59 CST 2024, time=2024-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187892, encodeId=7532218e892f6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第18天 receiving editor assigned , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cfc5136363, createdName=1466852am60暂无昵称, createdTime=Sun Feb 18 09:21:54 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182759, encodeId=88202182e5978, content=请问8天后收到邮件说推荐编辑Receiving Editor ,这个怎么弄呀朋友们?<br>In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:17:38 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2179649, encodeId=678021e9649f8, content=一审需要多久呀,被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Jan 06 20:16:05 CST 2024, time=2024-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161198, encodeId=20ad2161198f2, content=投稿15天,decision made,有人遇到过吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1191007765, createdTime=Fri Oct 06 16:52:29 CST 2023, time=2023-10-06, status=1, ipAttribution=江苏省)]
    2023-11-14 ms6000001571479804 来自湖北省

    10.25 under consideration,11.13 Decision Made
    是不是凉了?

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2168454, encodeId=71b521684548f, content=10.25 under consideration,11.13 Decision Made <br>是不是凉了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Tue Nov 14 14:23:49 CST 2023, time=2023-11-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171915, encodeId=c00021e19157e, content=审稿速度:1.0<br>经验分享:投稿9天了,还没有分配编辑。正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Nov 29 19:12:44 CST 2023, time=2023-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174411, encodeId=00cd21e441127, content=12月3日投稿,12月12日分配编辑,状态从under consideration变成decision made,等的很心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231212/49c44b7487594cb2a1457534d314b6f1/47f94596e582468ca6223cd97aa1f914.jpg, createdBy=a7645496639, createdName=ms9000001631056614, createdTime=Tue Dec 12 10:00:50 CST 2023, time=2023-12-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2112903, encodeId=38b6211290323, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:分子生物学;细胞生物<br>经验分享:做的泛素化和肿瘤相关的,我发现大CDD特别喜欢泛素化领域的,可以说是非常对口了。2022年7月份投稿,审稿特别快我记得只用了20天左右,但21年也投过一次审了50多天,这个不好说感觉看运气。这次三个审稿人,总共提大概20个问题(在这之前也投过其他杂志修过稿,估计也提不出太多),给了4个月修稿。每个问题都按要求非常仔细的修改或补充实验,花了刚好3个月时间修回。二审用了17天,所有审稿人对修改稿非常满意,被告知原则性接收。接下来按编辑的要求修改格式提交终稿等等,但提交后等了好久没消息,可能是因为年底欧洲那边休假比较多吧(也可能和世界杯有关系。。),一个月后才正式接收。最后交版面费和校稿等又花了一个月正式online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230911/cbd6c125e27947f9b1410a5defdb543f/5001c9b5eb424717bd69704b333cad05.jpg, createdBy=11262341875, createdName=12291c48m73(暂无昵称), createdTime=Fri Feb 03 17:00:45 CST 2023, time=2023-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2188705, encodeId=5ed52188e0542, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:上皮间质转化<br>经验分享:在投,想问以下,在投稿系统选择转投小CDD,是在大CDD拒稿后会发链接让转投吗,还是直接就转了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13c25384818, createdName=大鱼659, createdTime=Thu Feb 22 15:55:59 CST 2024, time=2024-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187892, encodeId=7532218e892f6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第18天 receiving editor assigned , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cfc5136363, createdName=1466852am60暂无昵称, createdTime=Sun Feb 18 09:21:54 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182759, encodeId=88202182e5978, content=请问8天后收到邮件说推荐编辑Receiving Editor ,这个怎么弄呀朋友们?<br>In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:17:38 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2179649, encodeId=678021e9649f8, content=一审需要多久呀,被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Jan 06 20:16:05 CST 2024, time=2024-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161198, encodeId=20ad2161198f2, content=投稿15天,decision made,有人遇到过吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1191007765, createdTime=Fri Oct 06 16:52:29 CST 2023, time=2023-10-06, status=1, ipAttribution=江苏省)]
    2023-11-29 丹丹同学 来自江苏省

    审稿速度:1.0
    经验分享:投稿9天了,还没有分配编辑。正常吗

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2168454, encodeId=71b521684548f, content=10.25 under consideration,11.13 Decision Made <br>是不是凉了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Tue Nov 14 14:23:49 CST 2023, time=2023-11-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171915, encodeId=c00021e19157e, content=审稿速度:1.0<br>经验分享:投稿9天了,还没有分配编辑。正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Nov 29 19:12:44 CST 2023, time=2023-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174411, encodeId=00cd21e441127, content=12月3日投稿,12月12日分配编辑,状态从under consideration变成decision made,等的很心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231212/49c44b7487594cb2a1457534d314b6f1/47f94596e582468ca6223cd97aa1f914.jpg, createdBy=a7645496639, createdName=ms9000001631056614, createdTime=Tue Dec 12 10:00:50 CST 2023, time=2023-12-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2112903, encodeId=38b6211290323, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:分子生物学;细胞生物<br>经验分享:做的泛素化和肿瘤相关的,我发现大CDD特别喜欢泛素化领域的,可以说是非常对口了。2022年7月份投稿,审稿特别快我记得只用了20天左右,但21年也投过一次审了50多天,这个不好说感觉看运气。这次三个审稿人,总共提大概20个问题(在这之前也投过其他杂志修过稿,估计也提不出太多),给了4个月修稿。每个问题都按要求非常仔细的修改或补充实验,花了刚好3个月时间修回。二审用了17天,所有审稿人对修改稿非常满意,被告知原则性接收。接下来按编辑的要求修改格式提交终稿等等,但提交后等了好久没消息,可能是因为年底欧洲那边休假比较多吧(也可能和世界杯有关系。。),一个月后才正式接收。最后交版面费和校稿等又花了一个月正式online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230911/cbd6c125e27947f9b1410a5defdb543f/5001c9b5eb424717bd69704b333cad05.jpg, createdBy=11262341875, createdName=12291c48m73(暂无昵称), createdTime=Fri Feb 03 17:00:45 CST 2023, time=2023-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2188705, encodeId=5ed52188e0542, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:上皮间质转化<br>经验分享:在投,想问以下,在投稿系统选择转投小CDD,是在大CDD拒稿后会发链接让转投吗,还是直接就转了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13c25384818, createdName=大鱼659, createdTime=Thu Feb 22 15:55:59 CST 2024, time=2024-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187892, encodeId=7532218e892f6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第18天 receiving editor assigned , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cfc5136363, createdName=1466852am60暂无昵称, createdTime=Sun Feb 18 09:21:54 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182759, encodeId=88202182e5978, content=请问8天后收到邮件说推荐编辑Receiving Editor ,这个怎么弄呀朋友们?<br>In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:17:38 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2179649, encodeId=678021e9649f8, content=一审需要多久呀,被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Jan 06 20:16:05 CST 2024, time=2024-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161198, encodeId=20ad2161198f2, content=投稿15天,decision made,有人遇到过吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1191007765, createdTime=Fri Oct 06 16:52:29 CST 2023, time=2023-10-06, status=1, ipAttribution=江苏省)]
    2023-12-12 ms9000001631056614 来自黑龙江省

    12月3日投稿,12月12日分配编辑,状态从under consideration变成decision made,等的很心焦

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2168454, encodeId=71b521684548f, content=10.25 under consideration,11.13 Decision Made <br>是不是凉了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Tue Nov 14 14:23:49 CST 2023, time=2023-11-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171915, encodeId=c00021e19157e, content=审稿速度:1.0<br>经验分享:投稿9天了,还没有分配编辑。正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Nov 29 19:12:44 CST 2023, time=2023-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174411, encodeId=00cd21e441127, content=12月3日投稿,12月12日分配编辑,状态从under consideration变成decision made,等的很心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231212/49c44b7487594cb2a1457534d314b6f1/47f94596e582468ca6223cd97aa1f914.jpg, createdBy=a7645496639, createdName=ms9000001631056614, createdTime=Tue Dec 12 10:00:50 CST 2023, time=2023-12-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2112903, encodeId=38b6211290323, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:分子生物学;细胞生物<br>经验分享:做的泛素化和肿瘤相关的,我发现大CDD特别喜欢泛素化领域的,可以说是非常对口了。2022年7月份投稿,审稿特别快我记得只用了20天左右,但21年也投过一次审了50多天,这个不好说感觉看运气。这次三个审稿人,总共提大概20个问题(在这之前也投过其他杂志修过稿,估计也提不出太多),给了4个月修稿。每个问题都按要求非常仔细的修改或补充实验,花了刚好3个月时间修回。二审用了17天,所有审稿人对修改稿非常满意,被告知原则性接收。接下来按编辑的要求修改格式提交终稿等等,但提交后等了好久没消息,可能是因为年底欧洲那边休假比较多吧(也可能和世界杯有关系。。),一个月后才正式接收。最后交版面费和校稿等又花了一个月正式online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230911/cbd6c125e27947f9b1410a5defdb543f/5001c9b5eb424717bd69704b333cad05.jpg, createdBy=11262341875, createdName=12291c48m73(暂无昵称), createdTime=Fri Feb 03 17:00:45 CST 2023, time=2023-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2188705, encodeId=5ed52188e0542, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:上皮间质转化<br>经验分享:在投,想问以下,在投稿系统选择转投小CDD,是在大CDD拒稿后会发链接让转投吗,还是直接就转了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13c25384818, createdName=大鱼659, createdTime=Thu Feb 22 15:55:59 CST 2024, time=2024-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187892, encodeId=7532218e892f6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第18天 receiving editor assigned , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cfc5136363, createdName=1466852am60暂无昵称, createdTime=Sun Feb 18 09:21:54 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182759, encodeId=88202182e5978, content=请问8天后收到邮件说推荐编辑Receiving Editor ,这个怎么弄呀朋友们?<br>In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:17:38 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2179649, encodeId=678021e9649f8, content=一审需要多久呀,被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Jan 06 20:16:05 CST 2024, time=2024-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161198, encodeId=20ad2161198f2, content=投稿15天,decision made,有人遇到过吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1191007765, createdTime=Fri Oct 06 16:52:29 CST 2023, time=2023-10-06, status=1, ipAttribution=江苏省)]
    2023-02-03 12291c48m73(暂无昵称) 来自广东省

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:分子生物学;细胞生物
    经验分享:做的泛素化和肿瘤相关的,我发现大CDD特别喜欢泛素化领域的,可以说是非常对口了。2022年7月份投稿,审稿特别快我记得只用了20天左右,但21年也投过一次审了50多天,这个不好说感觉看运气。这次三个审稿人,总共提大概20个问题(在这之前也投过其他杂志修过稿,估计也提不出太多),给了4个月修稿。每个问题都按要求非常仔细的修改或补充实验,花了刚好3个月时间修回。二审用了17天,所有审稿人对修改稿非常满意,被告知原则性接收。接下来按编辑的要求修改格式提交终稿等等,但提交后等了好久没消息,可能是因为年底欧洲那边休假比较多吧(也可能和世界杯有关系。。),一个月后才正式接收。最后交版面费和校稿等又花了一个月正式online。

    7

    展开7条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2168454, encodeId=71b521684548f, content=10.25 under consideration,11.13 Decision Made <br>是不是凉了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Tue Nov 14 14:23:49 CST 2023, time=2023-11-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171915, encodeId=c00021e19157e, content=审稿速度:1.0<br>经验分享:投稿9天了,还没有分配编辑。正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Nov 29 19:12:44 CST 2023, time=2023-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174411, encodeId=00cd21e441127, content=12月3日投稿,12月12日分配编辑,状态从under consideration变成decision made,等的很心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231212/49c44b7487594cb2a1457534d314b6f1/47f94596e582468ca6223cd97aa1f914.jpg, createdBy=a7645496639, createdName=ms9000001631056614, createdTime=Tue Dec 12 10:00:50 CST 2023, time=2023-12-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2112903, encodeId=38b6211290323, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:分子生物学;细胞生物<br>经验分享:做的泛素化和肿瘤相关的,我发现大CDD特别喜欢泛素化领域的,可以说是非常对口了。2022年7月份投稿,审稿特别快我记得只用了20天左右,但21年也投过一次审了50多天,这个不好说感觉看运气。这次三个审稿人,总共提大概20个问题(在这之前也投过其他杂志修过稿,估计也提不出太多),给了4个月修稿。每个问题都按要求非常仔细的修改或补充实验,花了刚好3个月时间修回。二审用了17天,所有审稿人对修改稿非常满意,被告知原则性接收。接下来按编辑的要求修改格式提交终稿等等,但提交后等了好久没消息,可能是因为年底欧洲那边休假比较多吧(也可能和世界杯有关系。。),一个月后才正式接收。最后交版面费和校稿等又花了一个月正式online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230911/cbd6c125e27947f9b1410a5defdb543f/5001c9b5eb424717bd69704b333cad05.jpg, createdBy=11262341875, createdName=12291c48m73(暂无昵称), createdTime=Fri Feb 03 17:00:45 CST 2023, time=2023-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2188705, encodeId=5ed52188e0542, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:上皮间质转化<br>经验分享:在投,想问以下,在投稿系统选择转投小CDD,是在大CDD拒稿后会发链接让转投吗,还是直接就转了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13c25384818, createdName=大鱼659, createdTime=Thu Feb 22 15:55:59 CST 2024, time=2024-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187892, encodeId=7532218e892f6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第18天 receiving editor assigned , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cfc5136363, createdName=1466852am60暂无昵称, createdTime=Sun Feb 18 09:21:54 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182759, encodeId=88202182e5978, content=请问8天后收到邮件说推荐编辑Receiving Editor ,这个怎么弄呀朋友们?<br>In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:17:38 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2179649, encodeId=678021e9649f8, content=一审需要多久呀,被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Jan 06 20:16:05 CST 2024, time=2024-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161198, encodeId=20ad2161198f2, content=投稿15天,decision made,有人遇到过吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1191007765, createdTime=Fri Oct 06 16:52:29 CST 2023, time=2023-10-06, status=1, ipAttribution=江苏省)]
    2024-01-20 ms7000001151045825 来自黑龙江省

    请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection.

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2168454, encodeId=71b521684548f, content=10.25 under consideration,11.13 Decision Made <br>是不是凉了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Tue Nov 14 14:23:49 CST 2023, time=2023-11-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171915, encodeId=c00021e19157e, content=审稿速度:1.0<br>经验分享:投稿9天了,还没有分配编辑。正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Nov 29 19:12:44 CST 2023, time=2023-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174411, encodeId=00cd21e441127, content=12月3日投稿,12月12日分配编辑,状态从under consideration变成decision made,等的很心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231212/49c44b7487594cb2a1457534d314b6f1/47f94596e582468ca6223cd97aa1f914.jpg, createdBy=a7645496639, createdName=ms9000001631056614, createdTime=Tue Dec 12 10:00:50 CST 2023, time=2023-12-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2112903, encodeId=38b6211290323, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:分子生物学;细胞生物<br>经验分享:做的泛素化和肿瘤相关的,我发现大CDD特别喜欢泛素化领域的,可以说是非常对口了。2022年7月份投稿,审稿特别快我记得只用了20天左右,但21年也投过一次审了50多天,这个不好说感觉看运气。这次三个审稿人,总共提大概20个问题(在这之前也投过其他杂志修过稿,估计也提不出太多),给了4个月修稿。每个问题都按要求非常仔细的修改或补充实验,花了刚好3个月时间修回。二审用了17天,所有审稿人对修改稿非常满意,被告知原则性接收。接下来按编辑的要求修改格式提交终稿等等,但提交后等了好久没消息,可能是因为年底欧洲那边休假比较多吧(也可能和世界杯有关系。。),一个月后才正式接收。最后交版面费和校稿等又花了一个月正式online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230911/cbd6c125e27947f9b1410a5defdb543f/5001c9b5eb424717bd69704b333cad05.jpg, createdBy=11262341875, createdName=12291c48m73(暂无昵称), createdTime=Fri Feb 03 17:00:45 CST 2023, time=2023-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2188705, encodeId=5ed52188e0542, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:上皮间质转化<br>经验分享:在投,想问以下,在投稿系统选择转投小CDD,是在大CDD拒稿后会发链接让转投吗,还是直接就转了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13c25384818, createdName=大鱼659, createdTime=Thu Feb 22 15:55:59 CST 2024, time=2024-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187892, encodeId=7532218e892f6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第18天 receiving editor assigned , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cfc5136363, createdName=1466852am60暂无昵称, createdTime=Sun Feb 18 09:21:54 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182759, encodeId=88202182e5978, content=请问8天后收到邮件说推荐编辑Receiving Editor ,这个怎么弄呀朋友们?<br>In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:17:38 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2179649, encodeId=678021e9649f8, content=一审需要多久呀,被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Jan 06 20:16:05 CST 2024, time=2024-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161198, encodeId=20ad2161198f2, content=投稿15天,decision made,有人遇到过吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1191007765, createdTime=Fri Oct 06 16:52:29 CST 2023, time=2023-10-06, status=1, ipAttribution=江苏省)]
    2024-02-22 大鱼659 来自广东省

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向:上皮间质转化
    经验分享:在投,想问以下,在投稿系统选择转投小CDD,是在大CDD拒稿后会发链接让转投吗,还是直接就转了

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2168454, encodeId=71b521684548f, content=10.25 under consideration,11.13 Decision Made <br>是不是凉了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Tue Nov 14 14:23:49 CST 2023, time=2023-11-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171915, encodeId=c00021e19157e, content=审稿速度:1.0<br>经验分享:投稿9天了,还没有分配编辑。正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Nov 29 19:12:44 CST 2023, time=2023-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174411, encodeId=00cd21e441127, content=12月3日投稿,12月12日分配编辑,状态从under consideration变成decision made,等的很心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231212/49c44b7487594cb2a1457534d314b6f1/47f94596e582468ca6223cd97aa1f914.jpg, createdBy=a7645496639, createdName=ms9000001631056614, createdTime=Tue Dec 12 10:00:50 CST 2023, time=2023-12-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2112903, encodeId=38b6211290323, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:分子生物学;细胞生物<br>经验分享:做的泛素化和肿瘤相关的,我发现大CDD特别喜欢泛素化领域的,可以说是非常对口了。2022年7月份投稿,审稿特别快我记得只用了20天左右,但21年也投过一次审了50多天,这个不好说感觉看运气。这次三个审稿人,总共提大概20个问题(在这之前也投过其他杂志修过稿,估计也提不出太多),给了4个月修稿。每个问题都按要求非常仔细的修改或补充实验,花了刚好3个月时间修回。二审用了17天,所有审稿人对修改稿非常满意,被告知原则性接收。接下来按编辑的要求修改格式提交终稿等等,但提交后等了好久没消息,可能是因为年底欧洲那边休假比较多吧(也可能和世界杯有关系。。),一个月后才正式接收。最后交版面费和校稿等又花了一个月正式online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230911/cbd6c125e27947f9b1410a5defdb543f/5001c9b5eb424717bd69704b333cad05.jpg, createdBy=11262341875, createdName=12291c48m73(暂无昵称), createdTime=Fri Feb 03 17:00:45 CST 2023, time=2023-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2188705, encodeId=5ed52188e0542, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:上皮间质转化<br>经验分享:在投,想问以下,在投稿系统选择转投小CDD,是在大CDD拒稿后会发链接让转投吗,还是直接就转了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13c25384818, createdName=大鱼659, createdTime=Thu Feb 22 15:55:59 CST 2024, time=2024-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187892, encodeId=7532218e892f6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第18天 receiving editor assigned , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cfc5136363, createdName=1466852am60暂无昵称, createdTime=Sun Feb 18 09:21:54 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182759, encodeId=88202182e5978, content=请问8天后收到邮件说推荐编辑Receiving Editor ,这个怎么弄呀朋友们?<br>In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:17:38 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2179649, encodeId=678021e9649f8, content=一审需要多久呀,被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Jan 06 20:16:05 CST 2024, time=2024-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161198, encodeId=20ad2161198f2, content=投稿15天,decision made,有人遇到过吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1191007765, createdTime=Fri Oct 06 16:52:29 CST 2023, time=2023-10-06, status=1, ipAttribution=江苏省)]
    2024-02-18 1466852am60暂无昵称 来自广东省

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:第18天 receiving editor assigned

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2168454, encodeId=71b521684548f, content=10.25 under consideration,11.13 Decision Made <br>是不是凉了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Tue Nov 14 14:23:49 CST 2023, time=2023-11-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171915, encodeId=c00021e19157e, content=审稿速度:1.0<br>经验分享:投稿9天了,还没有分配编辑。正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Nov 29 19:12:44 CST 2023, time=2023-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174411, encodeId=00cd21e441127, content=12月3日投稿,12月12日分配编辑,状态从under consideration变成decision made,等的很心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231212/49c44b7487594cb2a1457534d314b6f1/47f94596e582468ca6223cd97aa1f914.jpg, createdBy=a7645496639, createdName=ms9000001631056614, createdTime=Tue Dec 12 10:00:50 CST 2023, time=2023-12-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2112903, encodeId=38b6211290323, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:分子生物学;细胞生物<br>经验分享:做的泛素化和肿瘤相关的,我发现大CDD特别喜欢泛素化领域的,可以说是非常对口了。2022年7月份投稿,审稿特别快我记得只用了20天左右,但21年也投过一次审了50多天,这个不好说感觉看运气。这次三个审稿人,总共提大概20个问题(在这之前也投过其他杂志修过稿,估计也提不出太多),给了4个月修稿。每个问题都按要求非常仔细的修改或补充实验,花了刚好3个月时间修回。二审用了17天,所有审稿人对修改稿非常满意,被告知原则性接收。接下来按编辑的要求修改格式提交终稿等等,但提交后等了好久没消息,可能是因为年底欧洲那边休假比较多吧(也可能和世界杯有关系。。),一个月后才正式接收。最后交版面费和校稿等又花了一个月正式online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230911/cbd6c125e27947f9b1410a5defdb543f/5001c9b5eb424717bd69704b333cad05.jpg, createdBy=11262341875, createdName=12291c48m73(暂无昵称), createdTime=Fri Feb 03 17:00:45 CST 2023, time=2023-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2188705, encodeId=5ed52188e0542, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:上皮间质转化<br>经验分享:在投,想问以下,在投稿系统选择转投小CDD,是在大CDD拒稿后会发链接让转投吗,还是直接就转了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13c25384818, createdName=大鱼659, createdTime=Thu Feb 22 15:55:59 CST 2024, time=2024-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187892, encodeId=7532218e892f6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第18天 receiving editor assigned , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cfc5136363, createdName=1466852am60暂无昵称, createdTime=Sun Feb 18 09:21:54 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182759, encodeId=88202182e5978, content=请问8天后收到邮件说推荐编辑Receiving Editor ,这个怎么弄呀朋友们?<br>In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:17:38 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2179649, encodeId=678021e9649f8, content=一审需要多久呀,被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Jan 06 20:16:05 CST 2024, time=2024-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161198, encodeId=20ad2161198f2, content=投稿15天,decision made,有人遇到过吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1191007765, createdTime=Fri Oct 06 16:52:29 CST 2023, time=2023-10-06, status=1, ipAttribution=江苏省)]
    2024-01-20 ms7000001151045825 来自黑龙江省

    请问8天后收到邮件说推荐编辑Receiving Editor ,这个怎么弄呀朋友们?
    In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection.

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2168454, encodeId=71b521684548f, content=10.25 under consideration,11.13 Decision Made <br>是不是凉了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Tue Nov 14 14:23:49 CST 2023, time=2023-11-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171915, encodeId=c00021e19157e, content=审稿速度:1.0<br>经验分享:投稿9天了,还没有分配编辑。正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Nov 29 19:12:44 CST 2023, time=2023-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174411, encodeId=00cd21e441127, content=12月3日投稿,12月12日分配编辑,状态从under consideration变成decision made,等的很心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231212/49c44b7487594cb2a1457534d314b6f1/47f94596e582468ca6223cd97aa1f914.jpg, createdBy=a7645496639, createdName=ms9000001631056614, createdTime=Tue Dec 12 10:00:50 CST 2023, time=2023-12-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2112903, encodeId=38b6211290323, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:分子生物学;细胞生物<br>经验分享:做的泛素化和肿瘤相关的,我发现大CDD特别喜欢泛素化领域的,可以说是非常对口了。2022年7月份投稿,审稿特别快我记得只用了20天左右,但21年也投过一次审了50多天,这个不好说感觉看运气。这次三个审稿人,总共提大概20个问题(在这之前也投过其他杂志修过稿,估计也提不出太多),给了4个月修稿。每个问题都按要求非常仔细的修改或补充实验,花了刚好3个月时间修回。二审用了17天,所有审稿人对修改稿非常满意,被告知原则性接收。接下来按编辑的要求修改格式提交终稿等等,但提交后等了好久没消息,可能是因为年底欧洲那边休假比较多吧(也可能和世界杯有关系。。),一个月后才正式接收。最后交版面费和校稿等又花了一个月正式online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230911/cbd6c125e27947f9b1410a5defdb543f/5001c9b5eb424717bd69704b333cad05.jpg, createdBy=11262341875, createdName=12291c48m73(暂无昵称), createdTime=Fri Feb 03 17:00:45 CST 2023, time=2023-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2188705, encodeId=5ed52188e0542, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:上皮间质转化<br>经验分享:在投,想问以下,在投稿系统选择转投小CDD,是在大CDD拒稿后会发链接让转投吗,还是直接就转了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13c25384818, createdName=大鱼659, createdTime=Thu Feb 22 15:55:59 CST 2024, time=2024-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187892, encodeId=7532218e892f6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第18天 receiving editor assigned , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cfc5136363, createdName=1466852am60暂无昵称, createdTime=Sun Feb 18 09:21:54 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182759, encodeId=88202182e5978, content=请问8天后收到邮件说推荐编辑Receiving Editor ,这个怎么弄呀朋友们?<br>In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:17:38 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2179649, encodeId=678021e9649f8, content=一审需要多久呀,被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Jan 06 20:16:05 CST 2024, time=2024-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161198, encodeId=20ad2161198f2, content=投稿15天,decision made,有人遇到过吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1191007765, createdTime=Fri Oct 06 16:52:29 CST 2023, time=2023-10-06, status=1, ipAttribution=江苏省)]
    2024-01-06 雨念 来自浙江省

    一审需要多久呀,被拒的概率大吗

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2168454, encodeId=71b521684548f, content=10.25 under consideration,11.13 Decision Made <br>是不是凉了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Tue Nov 14 14:23:49 CST 2023, time=2023-11-14, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171915, encodeId=c00021e19157e, content=审稿速度:1.0<br>经验分享:投稿9天了,还没有分配编辑。正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/70430ae1e7e0fc481e5ad3235d0e1916.jpg, createdBy=2b215328303, createdName=丹丹同学, createdTime=Wed Nov 29 19:12:44 CST 2023, time=2023-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2174411, encodeId=00cd21e441127, content=12月3日投稿,12月12日分配编辑,状态从under consideration变成decision made,等的很心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231212/49c44b7487594cb2a1457534d314b6f1/47f94596e582468ca6223cd97aa1f914.jpg, createdBy=a7645496639, createdName=ms9000001631056614, createdTime=Tue Dec 12 10:00:50 CST 2023, time=2023-12-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2112903, encodeId=38b6211290323, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:分子生物学;细胞生物<br>经验分享:做的泛素化和肿瘤相关的,我发现大CDD特别喜欢泛素化领域的,可以说是非常对口了。2022年7月份投稿,审稿特别快我记得只用了20天左右,但21年也投过一次审了50多天,这个不好说感觉看运气。这次三个审稿人,总共提大概20个问题(在这之前也投过其他杂志修过稿,估计也提不出太多),给了4个月修稿。每个问题都按要求非常仔细的修改或补充实验,花了刚好3个月时间修回。二审用了17天,所有审稿人对修改稿非常满意,被告知原则性接收。接下来按编辑的要求修改格式提交终稿等等,但提交后等了好久没消息,可能是因为年底欧洲那边休假比较多吧(也可能和世界杯有关系。。),一个月后才正式接收。最后交版面费和校稿等又花了一个月正式online。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230911/cbd6c125e27947f9b1410a5defdb543f/5001c9b5eb424717bd69704b333cad05.jpg, createdBy=11262341875, createdName=12291c48m73(暂无昵称), createdTime=Fri Feb 03 17:00:45 CST 2023, time=2023-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182760, encodeId=e52f2182e60f4, content=请问大家这个receiving editor怎么处理的哇? In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:34:52 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2188705, encodeId=5ed52188e0542, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:上皮间质转化<br>经验分享:在投,想问以下,在投稿系统选择转投小CDD,是在大CDD拒稿后会发链接让转投吗,还是直接就转了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13c25384818, createdName=大鱼659, createdTime=Thu Feb 22 15:55:59 CST 2024, time=2024-02-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2187892, encodeId=7532218e892f6, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:第18天 receiving editor assigned , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cfc5136363, createdName=1466852am60暂无昵称, createdTime=Sun Feb 18 09:21:54 CST 2024, time=2024-02-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182759, encodeId=88202182e5978, content=请问8天后收到邮件说推荐编辑Receiving Editor ,这个怎么弄呀朋友们?<br>In order to streamline the review process we have asked you to suggest a Receiving Editor you would like to administratively handle the manuscript. The editorial office for Cell Death and Differentiation will now process this request and send it to the most appropriate Receiving Editor, taking into account your selection., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=198d5502994, createdName=ms7000001151045825, createdTime=Sat Jan 20 00:17:38 CST 2024, time=2024-01-20, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2179649, encodeId=678021e9649f8, content=一审需要多久呀,被拒的概率大吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Jan 06 20:16:05 CST 2024, time=2024-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2161198, encodeId=20ad2161198f2, content=投稿15天,decision made,有人遇到过吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ee92574980, createdName=1191007765, createdTime=Fri Oct 06 16:52:29 CST 2023, time=2023-10-06, status=1, ipAttribution=江苏省)]
    2023-10-06 1191007765 来自江苏省

    投稿15天,decision made,有人遇到过吗?

    8

    展开8条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分